Phospholipid–Prednisolone Conjugates for Targeted IBD Therapy: Structural Design, Synthetic Approaches, Optimization, and Computational Evaluation

Sapir Ifrah, Adi Jabarin, Ludmila Yarmolinsky, Keren Cohen-Hagai, Mordechai Deutsch, Arik Dahan, Shimon Ben-Shabat · 2026

Read Phospholipid–Prednisolone Conjugates for Targeted IBD Therapy: Structural Design, Synthetic Approaches, Optimization, and Computational Evaluation by Sapir Ifrah, Adi Jabarin, Ludmila Yarmolinsky, Keren Cohen-Hagai, Mordechai Deutsch, Arik Dahan, Shimon Ben-Shabat (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13567021.txt.

Description

Steroid drugs calm inflammatory bowel disease but punish the whole body when used for long. Sapir Ifrah and six co-authors designed prodrug versions of prednisolone in 2026 that should wake up only inside inflamed gut tissue.

Each design links the drug to a phospholipid through a spacer, aiming at an enzyme that is overactive in inflamed intestine and can cut the link. The team built four variants with a reversed assembly order, then used docking and motion simulations on a computer to compare them. Spacer length changed how the molecule sat in the enzyme's grip and how the cut point lined up. The analysis picks design rules for the next, lab-built round of candidates.

Catalog record

CREATORSapir Ifrah, Adi Jabarin, Ludmila Yarmolinsky, Keren Cohen-Hagai, Mordechai Deutsch, Arik Dahan, Shimon Ben-Shabat
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE59 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13567021

Browse the full library · About the Tower of Babel